geneplanet d.o.o.
Latest round
- Series B
Last raised
- Jul 2023
Total raised
- $22M
Investors
- 5
About geneplanet d.o.o.
, also known as GenePlanet, operates as a biotechnology company that engages in developing tests for genetic therapeutics. The company was founded by its CEO, Marko Bitenc, and Nina Šterk.o. GenePlanet provides healthcare and lifestyle solutions, mainly genetic testing solutions, cancer screening, lifestyle DNA tests, employee benefits, and corporate wellness solutions for insurance companies and corporations. The company also provides home DNA tests, medical DNA tests, blood tests, MyHeart blood tests, MyAncestry DNA tests, and Microbiome tests, which users can buy from its e-commerce platform. In addition, the company offers a mobile application for both Android and iOS users. The company generates revenue by offering its services on a subscription-based pricing plan. The plans include premium (EUR 449), MyLifestyle (EUR 299), and MYHealth (EUR 299).
Who invested in geneplanet d.o.o.
5 investors across 1 round
See all investors in geneplanet d.o.o.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 13, 2023
Amount
$22M
Investors
Questions about geneplanet d.o.o.
Who invested in geneplanet d.o.o.?
geneplanet d.o.o. has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has geneplanet d.o.o. raised?
geneplanet d.o.o. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did geneplanet d.o.o. last raise money?
geneplanet d.o.o.'s most recent round on record is a Series B, in Jul 2023.
What does geneplanet d.o.o. do?
, also known as GenePlanet, operates as a biotechnology company that engages in developing tests for genetic therapeutics.
Where is geneplanet d.o.o. headquartered?
geneplanet d.o.o. is headquartered in Ljubljana, Slovenia.
Which VCs invest in companies like geneplanet d.o.o.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at geneplanet d.o.o.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like geneplanet d.o.o.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.